With 41 offices in 29 countries, White & Case LLP is a truly global law firm, uniquely positioned to help our clients achieve their ambitions in today’s G20 world. As a pioneering international law firm, our cross-border experience and diverse team of local, US and English-qualified lawyers consistently deliver results for our clients. As a full-service firm in both established and emerging markets, we work with some of the world’s most established banks and businesses as well as start-up visionaries, governments and state-owned entities.
Our global competition group consistently ranks as one of the top antitrust practices in the world, with more than 190 experienced competition practitioners in 21 of our offices across 14 countries worldwide. Our experience includes government and private litigation, trials and appeals, mergers, acquisitions and joint ventures, and numerous precedent-setting wins for our clients. In the pharmaceutical sector, we have unparalleled experience. According to Global Competition Review in 2016, ‘No firm is more prolific or successful in handling major antitrust litigation targeting the pharmaceutical industry than White & Case’.
A key feature of our practice is in handling matters of first impression relating to the cutting-edge, fast-moving area at the intersection between IP and antitrust in the pharmaceutical industry. Our work on behalf of pharmaceutical clients includes defense against challenges to ‘reverse payment’ patent settlement agreements, ‘product-hopping’, claims of Walker Process fraud before the US Patent and Trademark Office, ‘sham’ IP enforcement and US Food and Drug Administration petitioning, and other allegations of improper conduct to delay or inhibit competition. In the US, we have extensive experience litigating claims brought by both private class action and opt-out plaintiffs as well as the US Federal Trade Commission and US Department of Justice.